About This Journal:

  • Print This Page
  • Subscribe to an RSS Feed
LOGIN
My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Cannabis and Cannabinoid Research

Editor-in-Chief: Daniele Piomelli, PhD, PharmD

• Online ISSN: 2378-8763 • Continuous Publication

Current Volume: 2

Featured Press Releases and Editorial Content

  • Do Cannabis Dispensary Staff Receive Sufficient Training?...Read More
  • Do Cannabis Users Think Package Warnings Are Needed?...Read More
  • Does Oral Cannabidiol Convert to THC, a Psychoactive Form of Cannabinoid, in the Stomach?...Read More
  • Cannabis and Cannabinoid Research Now Publishing in Collaboration with the International Association for Cannabinoid Medicines...Read More
  • Is Cannabis Addictive? Are There Treatments? Answers in New Journal's Roundtable Discussion...Read More
  • Cannabis and Cannabinoid Research Now Publishing in Collaboration with the International Cannabinoid Research Society...Read More
  • French Drug Trial Details Murky, Should Not Influence Future Cannabinoid Research...Read More
  • Dr. Daniele Piomelli Appointed Editor-in-Chief of Cannabis and Cannabinoid Research..Read More
  • New Cannabis and Cannabinoid Research Journal Commends President Obama’s Signal of Support for Medical Marijuana...Read More
  • New Open Access Journal on Cannabis and Cannabinoid Research Launching Fall 2015...Read More

Overview

Cannabis and Cannabinoid Research is the only peer-reviewed open access journal dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the endocannabinoid system. The Journal publishes a broad range of human and animal studies including basic and translational research; clinical studies; behavioral, social, and epidemiological issues; and ethical, legal, and regulatory controversies.

Cannabis and Cannabinoid Research is the premier open source for authoritative cannabis and cannabinoid research, discussion, and debate. The Journal publishes under the Creative Commons Attribution 4.0 (CC BY) license to ensure broad dissemination and participation. All articles in Cannabis and Cannabinoid Research are rapidly reviewed and published online within 4 weeks of acceptance.

Cannabis and Cannabinoid Research coverage includes:

  • Biochemical process of the endocannabinoid system
  • Cannabinoid receptors and signaling
  • Pharmaceuticals based on cannabis and cannabinoids
  • Optimal dosing and drug delivery
  • Short- and long-term effects on the brain and behavior
  • Toxicological studies
  • Analgesic effects, including neuropathic pain and chronic nerve injury
  • Neurological disorders, including epilepsy, multiple sclerosis, and glaucoma
  • Use of cannabis as antinauseants and antispasmodics
  • Immune function and chronic inflammation, including HIV
  • Cancer and cancer-related treatment
  • Screening and assessment for marijuana misuse and addiction
  • Social, behavioral, and public health impact
  • Ethics, regulation, legalization, and public policy

Cannabis and Cannabinoid Research is under the editorial leadership of Daniele Piomelli, PhD, PharmD, the Louise Turner Arnold Chair in Neurosciences and Professor of Anatomy and Neurobiology, Pharmacology, and Biological Chemistry at University of California, Irvine.

Audience: Pharmacologists and psychopharmacologists, toxicologists, biochemists, neurologists, psychiatrists, physicians, and other healthcare practitioners, addiction specialists, and regulators and policymakers, among others

 

Benefits of publishing in Cannabis and Cannabinoid Research:

  • High visibility, immediate and unrestricted online access to published articles
  • Rigorous and rapid peer review
  • Easy compliance with open access mandates
  • Authors retain copyright
  • Highly indexed – citation tracking and inclusion in bibliographic databases
  • Targeted email marketing

 

Society Affiliation


In Collaboration with International Cannabinoid Research Society and International Association for Cannabinoid Medicines

Publisher Contact
Jordan Schilling
Director of Open Access Publishing
Mary Ann Liebert, Inc., publishers
140 Huguenot Street, 3rd Floor
New Rochelle, NY 10801
Phone: 914-740-2100

Indexed/Abstracted in:

PubMed; PubMed Central; ProQuest databases
 

Come See Us!

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Journal of Palliative Medicine

    Journal of Palliative Medicine

    The leading interdisciplinary journal reporting on the clinical, educational, legal, and ethical aspects of palliative care for patients in end of life or with intractable pain, focusing on improving quality of life.

    Journal of Caffeine Research

    Journal of Caffeine Research

    The first and only peer-reviewed journal dedicated to caffeine science, addressing the need for an authoritative source for advancing knowledge of caffeine science and its effects on human health.

    Journal of Child and Adolescent Psychopharmacology

    Journal of Child and Adolescent Psychopharmacology

    Developmental Psychopathology and Therapeutics

    The peer-reviewed journal covering the clinical aspects of treating this patient population with psychotropic medications including side effects and interactions, standard doses, and research on new and existing medications.

    Journal of Alternative and Complementary Medicine, The

    Journal of Alternative and Complementary Medicine, The

    The premier peer-reviewed journal of scientific work for healthcare professionals, practitioners, and scientists seeking to evaluate and integrate Complementary and Alternative Medicine (CAM) into mainstream practice.

Browse All Publications »

Editor-in-Chief, Dr. Piomelli Testifies at Senate Hearing on Medical Cannabis